The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages.
Phage therapy may become a complement to antibiotics in the treatment of chronic Pseudomonas aeruginosa infection. To design efficient therapeutic cocktails, the genetic diversity of the species and the spectrum of susceptibility to bacteriophages must be investigated. Bacterial strains showing high...
Enregistré dans:
Auteurs principaux: | Christiane Essoh, Yann Blouin, Guillaume Loukou, Arsher Cablanmian, Serge Lathro, Elizabeth Kutter, Hoang Vu Thien, Gilles Vergnaud, Christine Pourcel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bfee257388a24b4c8fcd67fbefcab8f7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A novel Pseudomonas aeruginosa bacteriophage, Ab31, a chimera formed from temperate phage PAJU2 and P. putida lytic phage AF: characteristics and mechanism of bacterial resistance.
par: Libera Latino, et autres
Publié: (2014) -
Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa
par: Sonika Sharma, et autres
Publié: (2021) -
Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
par: Carla López-Causapé, et autres
Publié: (2017) -
The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
par: Amanda J. Morris, et autres
Publié: (2021) -
Molecular analysis of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
par: Dariusz Jarych, et autres
Publié: (2021)